Imagion Bio at The Edison Open House: Global Healthcare 2022

Our CEO, Bob Proulx, connected with the Edison Group during their Global Healthcare Open House to discuss in detail, the nanotechnology behind our bio-imaging MagSense technology and where we hope to make a big difference in early cancer detection.

Watch the full interview here:

Visit our technology pages to learn more about our PrecisionMRX Nanoparticles or our MagSense Technology.

CONTACT US with any questions.